The U.S. Food and Drug Administration (FDA) has recently made an important announcement that will have a significant impact on the cosmetic industry. In a move aimed at providing the industry with additional time to meet compliance requirements, the FDA has decided to delay the enforcement of the cosmetic product facility registration and product listing regulations under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Understanding the Delay
The FDA’s decision to delay enforcement comes as a response to the ever-evolving landscape of cosmetic product manufacturing and processing. The extension of the enforcement deadline by six months is designed to ensure that cosmetic businesses have sufficient time to submit the necessary facility registration and product listing information. As a result, this adjustment in the timeline is expected to ease the transition to compliance with MoCRA regulations.
The Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Listing Guidance Document outlines the specifics of this extension, stating that the agency will commence enforcement on July 1, 2024. It’s important to note that this new enforcement date applies universally to all facilities engaged in cosmetic product manufacturing and processing, irrespective of when they initiated their operations.
No Changes to the Regulation
Crucially, this delay in enforcement does not signify any changes to the MoCRA regulation itself. It is essential for businesses in the cosmetic industry to understand that the regulatory requirements remain consistent. Therefore, it is strongly recommended that all cosmetic facilities proactively work towards submitting their registration information by December 29, 2023, if feasible. Similarly, responsible individuals should begin preparing product listing information for submission to the FDA by the same date, where possible.
Stay Informed with CE.way
At CE.way, we are committed to keeping our clients informed and up-to-date with the latest developments in regulatory compliance. As new information becomes available, we will continue to provide updates to ensure that your business remains well-prepared and compliant with the evolving regulatory landscape.
The FDA’s decision to delay the enforcement of cosmetic registration requirements is a crucial development for the industry. By staying informed and acting proactively, businesses can ensure a smoother transition to compliance with MoCRA regulations and maintain their commitment to product safety and transparency.
